Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV

12/19/24 • 12 min

Hippo Education Presents: The Monthly Rounds

Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it. Explore Our Podcasts: hippoed.com/podcasts

Previous Episode

Primary Care RAP - Lipidology 201: Advanced Testing

Patients sometimes ask us about further testing for lipids beyond the standard lipid profile. Neda Frayha sits down with cardiologist, Dr. Stanley Liu, to dive into advanced testing for lipids and how to evaluate and treat the results of that testing. Explore Our Podcasts: hippoed.com/podcasts

Next Episode

Peds RAP - Down Syndrome Part 1

Down Syndrome or Trisomy 21, is one of the most commonly encountered syndromes seen in the primary care office. Guidelines for the care of the patient with Down Syndrome has changed several times in the past couple of decades, and in keeping with this tradition, the AAP came out with yet another set of guidelines in May of 2022. This Clinical Report for the Health Supervision of Patients with Down Syndrome is packed with awesome updates and tips of how to successfully navigate the well child encounter, and is a must read for every primary care provider. Here to help us unpack this great bundle of information is Dr. Eyal Ben-Isaac, general pediatrician from CHLA. Explore Our Podcasts: hippoed.com/podcasts